专题：Hepatitis C virus research

This cluster of papers focuses on the epidemiology, treatment, and outcomes of hepatitis C virus infection. It covers topics such as antiviral therapy, genetic variation in viral clearance, global epidemiology, liver-related mortality, immune responses, and the impact of comorbidities like HIV and diabetes.
最新文献
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

article Full Text OpenAlex

Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation

article Full Text OpenAlex

CD4+ T‐cell recovery in HIV/hepatitis C co‐infected patients following successful hepatitis C treatment

article Full Text OpenAlex

Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients

review Full Text OpenAlex

Child–Pugh grade deterioration stratified by the etiology after transcatheter arterial chemoembolization as initial treatment for hepatocellular carcinoma

article Full Text OpenAlex

Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study

article Full Text OpenAlex

Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study

article Full Text OpenAlex

Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infection

article Full Text OpenAlex

The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools)

article Full Text OpenAlex

Post-Liver Transplant Metabolic Syndrome

article Full Text OpenAlex

近5年高被引文献
Hepatocellular carcinoma

review Full Text OpenAlex 5774 FWCI756.60826647

Advancing the global public health agenda for NAFLD: a consensus statement

review Full Text OpenAlex 664 FWCI98.9397484

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

review Full Text OpenAlex 592 FWCI111.34427315

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

article Full Text OpenAlex 508 FWCI88.40113129

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

review Full Text OpenAlex 499 FWCI75.04486577

Corrigendum to ‘EASL recommendations on treatment of hepatitis C: Final update of the series’ [J Hepatol 73 (2020) 1170–1218]

erratum Full Text OpenAlex 448 FWCI26.85030533

Immunobiology and pathogenesis of hepatitis B virus infection

review Full Text OpenAlex 443 FWCI61.97735183

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

article Full Text OpenAlex 440 FWCI98.74550767

Hepatitis B

review Full Text OpenAlex 421 FWCI148.6359009

Global burden of hepatitis B virus: current status, missed opportunities and a call for action

review Full Text OpenAlex 421 FWCI148.6359009